The latest immunotherapy news and developments
Potent oral agent that acts as both immunotherapy and targeted treatment produces high response rate in patients with hard-to-treat and refractory multiple myeloma when combined with steroid
A new agent that subverts myeloma cells from within while also subjecting them to an…